Why Biotech Boomer Intercept Pharmaceuticals, Inc. Tumbled Again

High-flying biotech Intercept Pharmaceuticals (NASDAQ: ICPT  ) enjoyed a 516% gain last week, but shares have tumbled this week. After yesterday's 18% dive, shares dropped another 30% today. In the following video, analyst Max Macaluso discusses what caused today's drop and the key issues that long-term investors need to focus on.

Stock picks for the ultimate growth portfolio
They said it couldn't be done. But David Gardner has proved them wrong time, and time, and time again with stock returns like 926%, 2,239%, and 4,371%. In fact, just recently one of his favorite stocks became a 100-bagger. And he's ready to do it again. You can uncover his scientific approach to crushing the market and his carefully chosen six picks for ultimate growth instantly, because he's making this premium report free for you today. Click here now for access.

Read/Post Comments (2) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 15, 2014, at 11:17 PM, ninderad wrote:


  • Report this Comment On January 16, 2014, at 12:23 AM, ninderad wrote:

    Recent Fool.Com articles and videos only highlightened the negatives of the ICPT product.

    If you read the other articles hereabouts:

    1. NASH patients usually "obees" with abnormal cholesterol. So go to your diettist to program your fat diet ( for example maximum 2 hamburgers instead of 4!) and take exercise to get rid of the surplus calories.

    2. The studies shows ICPT product stop the evolution of NASH or cure the NASH. My choice is simple; I will take ICPT product or die because of NASH.

    3. Institutions owns 53% ICPT and yesterday bump 10.25%! They are coming back!

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2795383, ~/Articles/ArticleHandler.aspx, 8/28/2015 1:46:05 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Max Macaluso

Max is the Technology, Biopharma & Health Care Bureau Chief at Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.

Today's Market

updated 4 hours ago Sponsored by:
DOW 16,654.77 369.26 2.27%
S&P 500 1,987.66 47.15 2.43%
NASD 4,812.71 115.17 2.45%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/27/2015 4:00 PM
ICPT $189.34 Up +4.37 +2.36%
Intercept Pharmace… CAPS Rating: **